Product Images Plegisol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Plegisol NDC 0409-7969 by Hospira, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Logo - plegisol 01

Logo - plegisol 01

IV Bag NDC 0409-7969-05 - plegisol 02

IV Bag NDC 0409-7969-05 - plegisol 02

This is a set of instructions for preparing and administering Sodium Bicarbonate Injection using aseptic technique. It highlights the requirement of 10 mL of 8.4% Sodium Bicarbonate Injection Hospira List 4900, prior to use. It provides instruction to affix an additive label over the label on the flexible container. Additionally, it informs the user to check for minute leaks by gently squeezing the container after removing the overwrap, and to discard the solution if leaks are found. Storage directions are also given, including protecting the solution from freezing, with a reference to a USP Controlled Room Temperature. The presence of natural rubber latex in the product is also indicated.*

PRINCIPAL DISPLAY PANEL - Pouch Label - plegisol 03

PRINCIPAL DISPLAY PANEL - Pouch Label - plegisol 03

This is a description of Plegisol®, Hospira's Cardioplegic Solution, a solution for cardiac perfusion that should not be injected intravenously. It comes in a 100 mL container that contains sodium chloride, calcium chloride, magnesium chloride, and potassium chloride, and may contain HCI and/or NaOH for pH adjustment. Prior to usage, 10 mL of 8.4% Sodium Bicarbonate Injection, USP, Hospira List 4900, is required to adjust the pH to approximately 7.8 at room temperature. The distribution of Plegisol® is done by Hospira, Inc., and it should not be stored longer than 24 hours. Consult with a pharmacist if additives are being introduced. This solution must not be used in series connection, and the usual dosage can be found in the insert.*

plegisol 04

plegisol 04

This is a description of PLEGISOL, Hospira's cardioplegic solution contained in a Single-dose container of 1000 mL with an additive label. The solution contains electrolytes such as Sodium, potassium, magnesium, calcium, chloride, and bicarbonate for patient use. It also warns on the label that the solution is not meant for intravenous injection. 10 mL of 8.4% Sodium Bicarbonate Injection, USP, Hospira List 4900, was added to adjust the pH of the solution to about 7.8. The additive should be stored in under refrigeration and not longer than 24 hours; it should be kept cool before use. The recommended dosage is available in the insert and unused portions need to be discarded. The product is distributed by Hospira, Inc. based in Lake Forest, IL.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.